Bruhn Suzanne Louise
Insider CIK 1517790 · RPTP Director · RTRX Director · CERC Director · AGLE Director · PLRX Director · MNMD Director · VIGL Director · NVLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics, Inc | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 24,289 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 32,750 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 33,875 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 18,068 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 24,073 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 6,235 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 24,310 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 5,000 | — | $0 | 0 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2025-06-12 | 2025-06-16 | 75,187 | — | $0 | 75,187 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award | 2025-05-22 | 2025-05-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 28,750 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 33,875 | — | $0 | 33,875 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2024-06-10 | 2024-06-12 | 16,506 | — | $0 | 16,506 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 18,068 | — | $0 | 18,068 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 22,250 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 6,235 | $7.62 | $47.5K | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 24,310 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 24,310 | — | $0 | 24,310 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 6,235 | — | $0 | 6,235 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 13,928 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-05 | 24,073 | — | $0 | 24,073 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2023-06-21 | 2023-06-23 | 19,203 | — | $0 | 27,267 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award | 2023-06-21 | 2023-06-23 | 13,671 | — | $0 | 19,623 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 13,928 | — | $0 | 13,928 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 15,750 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 6,235 | $7.62 | $47.5K | 6,235 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2022-08-11 | 2022-08-15 | 120,968 | — | $0 | 120,968 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2022-08-11 | 2022-08-15 | 503,773 | — | $0 | 503,773 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award | 2022-08-11 | 2022-08-15 | 89,286 | — | $0 | 89,286 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-07-27 | 2022-07-28 | 24,310 | — | $0 | 24,310 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 11,250 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2021-09-30 | 2021-10-04 | 5,204 | — | $0 | 5,204 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-06-30 | 2021-07-02 | 3,465 | — | $0 | 3,465 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-06-15 | 2021-06-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 8,250 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-03-31 | 2021-04-02 | 4,173 | — | $0 | 4,173 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-12-31 | 2021-01-05 | 4,254 | — | $0 | 4,254 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-09-30 | 2020-10-01 | 4,325 | — | $0 | 4,325 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 2,130 | — | $0 | 2,130 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2020-06-08 | 2020-06-10 | 28,100 | — | $0 | 28,100 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-04-24 | 2020-04-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-04-08 | 2020-04-09 | 15,750 | — | $0 | 15,750 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-04-08 | 2020-04-09 | 5,250 | — | $0 | 5,250 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-06-07 | 2019-06-07 | 12,400 | — | $0 | 12,400 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-08-09 | 2018-08-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-06-07 | 2018-06-08 | 18,400 | — | $0 | 18,400 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2017-10-02 | 2017-10-04 | 9,600 | — | $0 | 9,600 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-02-15 | 2017-02-16 | 82,000 | — | $0 | 82,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 90,000 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 30,680 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer | 2016-10-25 | 2016-10-26 | 8,330 | $9.00 | $75.0K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | U Tender | 2016-10-24 | 2016-10-26 | 48,437 | $9.00 | $435.9K | 8,330 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-06-23 | 2016-06-27 | 8,330 | — | $0 | 56,767 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2015-09-09 | 2015-09-11 | 15,000 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2015-09-09 | 2015-09-11 | 45,000 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2015-09-09 | 2015-09-11 | 15,000 | $5.13 | $77.0K | 66,695 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2015-09-09 | 2015-09-11 | 45,000 | $3.33 | $149.8K | 51,695 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2015-09-09 | 2015-09-11 | 18,258 | $12.47 | $227.7K | 48,437 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2015-06-10 | 2015-06-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2015-06-10 | 2015-06-11 | 30,000 | $13.45 | $403.5K | 6,695 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2015-06-10 | 2015-06-11 | 30,000 | $3.33 | $99.9K | 36,695 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2015-05-19 | 2015-05-21 | 18,996 | — | $0 | 18,996 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2015-05-19 | 2015-05-21 | 5,021 | — | $0 | 6,695 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2015-02-09 | 2015-02-11 | 6,332 | — | $0 | 6,332 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2015-02-09 | 2015-02-11 | 1,674 | — | $0 | 1,674 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2014-03-13 | 2014-03-17 | 2,760 | — | $0 | 30,680 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2014-03-13 | 2014-03-17 | 2,760 | $15.21 | $42.0K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2014-03-13 | 2014-03-17 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2014-02-13 | 2014-02-18 | 2,760 | — | $0 | 33,440 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2014-02-13 | 2014-02-18 | 2,760 | $14.98 | $41.3K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2014-02-13 | 2014-02-18 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2014-02-07 | 2014-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2014-01-13 | 2014-01-15 | 2,760 | — | $0 | 36,200 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2014-01-13 | 2014-01-15 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2014-01-13 | 2014-01-15 | 2,760 | $15.05 | $41.5K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2013-12-16 | 2013-12-18 | 2,760 | — | $0 | 38,960 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2013-12-16 | 2013-12-18 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2013-12-16 | 2013-12-18 | 2,760 | $13.19 | $36.4K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2013-11-13 | 2013-11-15 | 2,760 | — | $0 | 41,720 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2013-11-13 | 2013-11-15 | 2,760 | $13.00 | $35.9K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2013-11-13 | 2013-11-15 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2013-10-14 | 2013-10-16 | 2,760 | — | $0 | 44,480 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2013-10-14 | 2013-10-16 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2013-10-14 | 2013-10-16 | 2,760 | $13.58 | $37.5K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2013-09-13 | 2013-10-09 | 2,760 | — | $0 | 47,240 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2013-09-13 | 2013-10-09 | 2,760 | $5.49 | $15.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2013-09-13 | 2013-09-17 | 2,760 | — | $0 | 72,240 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2013-09-13 | 2013-09-17 | 2,760 | $3.33 | $9.2K | 2,760 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2013-09-13 | 2013-09-17 | 2,760 | $14.07 | $38.8K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2012-09-25 | 2012-09-27 | 50,000 | — | $0 | 230,000 | SEC↗ |